MedPath
Found 556472 clinical trials
Sort by:

Prevalence of Inappropriate Prescriptions and Omitted Therapies in Hospitalized Elderly: STOPP/START Criteria Analysis

Completed
Conditions
Polypharmacy (People Under Treatment With 5 or More Drugs)
Elderly (People Aged 65 or More)
Deprescribing
Hospitalization
First Posted Date
2025-10-02
Last Posted Date
2025-10-02
Lead Sponsor
Regione del Veneto - AULSS n. 7 Pedemontana
Target Recruit Count
100
Registration Number
NCT07202962
Locations
🇮🇹

Regione del Veneto - AULSS n. 7 Pedemontana, Santorso, Vicenza, Italy

Study of the Optimal Number of Repetitions to Investigate the Cerebral Activity by fNIRS During a Voluntary Movement and an Illusory Movement Induced by Vibration

Not yet recruiting
Conditions
Healthy
First Posted Date
2025-10-02
Last Posted Date
2025-10-02
Lead Sponsor
Centre Hospitalier Régional d'Orléans
Target Recruit Count
30
Registration Number
NCT07203807
Locations
🇫🇷

CHU Orléans, Orléans, France

Efficacy Study of Dexmedetomidine Nasal Spray Combined With Propofol for Deep Sedation in ERCP

Not Applicable
Not yet recruiting
Conditions
Dexmedetomidine Induced Sedation
Nasal Administration
Sprays
Interventions
Drug: Dexmedetomidine Injection (nasal spray) + Propofol Injection + Sufentanil Injection
Drug: Normal Saline (nasal spray) + Dexmedetomidine Injection (intravenous) + Propofol Injection + Sufentanil Injection
Drug: Regular sedation protocol
First Posted Date
2025-10-02
Last Posted Date
2025-10-02
Lead Sponsor
Shiyou Wei
Target Recruit Count
180
Registration Number
NCT07204106
Locations
🇨🇳

Shanghai East Hospital,Affiliated to Tongji University, Shanghai, Shanghai Municipality, China

Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL

Not Applicable
Recruiting
Conditions
Acute Lymphoblastic Leukemia
Interventions
Drug: targeted drug
First Posted Date
2025-10-02
Last Posted Date
2025-10-02
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
154
Registration Number
NCT07203352
Locations
🇨🇳

Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Circadian Health Regulation and Optimization for Rejuvenation Outcomes

Not Applicable
Recruiting
Conditions
Aging, Healthy
Blood Sugar; High
Blood Sugar (Glucose) Control
Time Restricted Eating
Circadian Dysregulation
First Posted Date
2025-10-02
Last Posted Date
2025-10-02
Lead Sponsor
Salk Institute for Biological Studies
Target Recruit Count
16
Registration Number
NCT07203196
Locations
🇺🇸

University of California San Diego, La Jolla, California, United States

Ring Free Gingival Techniqea

Not Applicable
Completed
Conditions
Free Gingival Graft Volume Change
First Posted Date
2025-10-02
Last Posted Date
2025-10-02
Lead Sponsor
Esra ATEŞ
Target Recruit Count
38
Registration Number
NCT07204717
Locations

Department of Periodontology, Faculty of Dentistry, Bolu Abant İzzet Baysal University,, Bolu, Bolu, Turkey (Türkiye)

Cervical Pre-cancer Treatment Failure Among Women Living With HIV in Zimbabwe

Recruiting
Conditions
Uterine Cervical Neoplasms
HIV I Infection
HPV Infection
First Posted Date
2025-10-02
Last Posted Date
2025-10-02
Lead Sponsor
University of Bern
Target Recruit Count
250
Registration Number
NCT07202936
Locations
🇿🇼

Women's Health Centre at Newlands Clinic, Harare, Zimbabwe

A Study of IPM514 in Patients With Esophageal Squamous Cell Carcinoma.

Not Applicable
Not yet recruiting
Conditions
Esophageal Squamous Cell Carcinoma
Interventions
First Posted Date
2025-10-02
Last Posted Date
2025-10-02
Lead Sponsor
Beijing Immupeutics Medicine Technology Limited
Target Recruit Count
36
Registration Number
NCT07203898

Additional Effects of Niel-asher Technique on Patients With Adhesive Capsulitis

Not Applicable
Not yet recruiting
Conditions
Adhesive Capsulitis
First Posted Date
2025-10-02
Last Posted Date
2025-10-02
Lead Sponsor
Riphah International University
Target Recruit Count
36
Registration Number
NCT07203963
Locations
🇵🇰

Shafi International Hospital, Islamabad, Punjab Province, Pakistan

A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administration in Healthy Adult Participants

Not Applicable
Not yet recruiting
Conditions
Healthy Volunteers
Interventions
Drug: Xanomeline/ Trospium Chloride
First Posted Date
2025-10-02
Last Posted Date
2025-10-02
Lead Sponsor
Karuna Therapeutics
Target Recruit Count
56
Registration Number
NCT07204418
Locations
🇺🇸

Local Institution - 0003, Anaheim, California, United States

🇺🇸

Local Institution - 0002, Lenexa, Kansas, United States

🇺🇸

Local Institution - 0001, San Antonio, Texas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.